Correction to: Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA. Zhao M, Zhao L, Yang Y, Wang F, et al. BMC Cancer 2026;26:139.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao M, Zhao L, Yang Y, Wang F, et al. Correction to: Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA. BMC Cancer 2026;26:139.
PMID: 41593578